{"id":"https://openalex.org/W2736687481","doi":"https://doi.org/10.1002/dta.2250","title":"Development and validation of an optical biosensor for rapid monitoring of adalimumab in serum of patients with Crohn's disease","display_name":"Development and validation of an optical biosensor for rapid monitoring of adalimumab in serum of patients with Crohn's disease","publication_year":2017,"publication_date":"2017-07-25","ids":{"openalex":"https://openalex.org/W2736687481","doi":"https://doi.org/10.1002/dta.2250","mag":"2736687481","pmid":"https://pubmed.ncbi.nlm.nih.gov/28743169"},"language":"en","primary_location":{"id":"doi:10.1002/dta.2250","doi":"https://doi.org/10.1002/dta.2250","is_oa":false,"landing_page_url":"https://doi.org/10.1002/dta.2250","pdf_url":null,"source":{"id":"https://openalex.org/S36361591","display_name":"Drug Testing and Analysis","issn_l":"1942-7603","issn":["1942-7603","1942-7611"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Testing and Analysis","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051376425","display_name":"Sumin Bian","orcid":"https://orcid.org/0000-0002-9470-8143","observed_orcids":["https://orcid.org/0000-0002-9470-8143"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Sumin Bian","raw_affiliation_strings":["Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium"],"raw_orcid":"https://orcid.org/0000-0002-9470-8143","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004919064","display_name":"Jiadi Lu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Jiadi Lu","raw_affiliation_strings":["Department of Biosystems-MeBioS, KU Leuven, Heverlee, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biosystems-MeBioS, KU Leuven, Heverlee, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000562959","display_name":"Filip Delport","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Filip Delport","raw_affiliation_strings":["Department of Biosystems-MeBioS, KU Leuven, Heverlee, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biosystems-MeBioS, KU Leuven, Heverlee, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019474609","display_name":"S\u00e9verine Vermeire","orcid":"https://orcid.org/0000-0001-9942-3019","observed_orcids":["https://orcid.org/0000-0001-9942-3019"]},"institutions":[{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"S\u00e9verine Vermeire","raw_affiliation_strings":["Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I2800231306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009911306","display_name":"Dragana Spasi\u0107","orcid":"https://orcid.org/0000-0001-9882-5091","observed_orcids":["https://orcid.org/0000-0001-9882-5091"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Dragana Spasic","raw_affiliation_strings":["Department of Biosystems-MeBioS, KU Leuven, Heverlee, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biosystems-MeBioS, KU Leuven, Heverlee, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064200316","display_name":"Jeroen Lammertyn","orcid":"https://orcid.org/0000-0001-8143-6794","observed_orcids":["https://orcid.org/0000-0001-8143-6794"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Jeroen Lammertyn","raw_affiliation_strings":["Department of Biosystems-MeBioS, KU Leuven, Heverlee, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biosystems-MeBioS, KU Leuven, Heverlee, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082317019","display_name":"Ann Gils","orcid":"https://orcid.org/0000-0002-1267-7161","observed_orcids":["https://orcid.org/0000-0002-1267-7161"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Ann Gils","raw_affiliation_strings":["Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5082317019"],"corresponding_institution_ids":["https://openalex.org/I99464096"],"apc_list":{"value":4440,"currency":"USD","value_usd":4440},"apc_paid":null,"fwci":1.3071,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.76778019,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"10","issue":"3","first_page":"592","last_page":"596"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.5023999810218811,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.5023999810218811,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12867","display_name":"Advanced Biosensing Techniques and Applications","score":0.17870000004768372,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11393","display_name":"Biosensors and Analytical Detection","score":0.13259999454021454,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.9539999961853027},{"id":"https://openalex.org/keywords/crohn-s-disease","display_name":"Crohn's disease","score":0.8669999837875366},{"id":"https://openalex.org/keywords/optical-biosensors","display_name":"optical biosensors","score":0.9629999995231628},{"id":"https://openalex.org/keywords/gold-nanoparticles","display_name":"gold nanoparticles","score":0.765999972820282},{"id":"https://openalex.org/keywords/point-of-care-testing","display_name":"point-of-care testing","score":0.8299999833106995},{"id":"https://openalex.org/keywords/serum-drug-quantification","display_name":"serum drug quantification","score":0.8479999899864197},{"id":"https://openalex.org/keywords/elisa-comparison","display_name":"ELISA comparison","score":0.7009999752044678}],"concepts":[{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.9631929397583008},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.6735828518867493},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.5942279696464539},{"id":"https://openalex.org/C106847996","wikidata":"https://www.wikidata.org/wiki/Q898756","display_name":"Surface plasmon resonance","level":3,"score":0.593817949295044},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5611781477928162},{"id":"https://openalex.org/C160756335","wikidata":"https://www.wikidata.org/wiki/Q669391","display_name":"Biosensor","level":2,"score":0.5552230477333069},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.44022083282470703},{"id":"https://openalex.org/C2779280984","wikidata":"https://www.wikidata.org/wiki/Q1472","display_name":"Crohn's disease","level":3,"score":0.43533551692962646},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30388593673706055},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2926902770996094},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.19419625401496887},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.1701495349407196},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.14770564436912537},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.13325053453445435},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.13216817378997803},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08231130242347717}],"mesh":[{"descriptor_ui":"D000068879","descriptor_name":"Adalimumab","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D003424","descriptor_name":"Crohn Disease","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003424","descriptor_name":"Crohn Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D020349","descriptor_name":"Surface Plasmon Resonance","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D020349","descriptor_name":"Surface Plasmon Resonance","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D055910","descriptor_name":"Antibodies, Immobilized","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D057230","descriptor_name":"Limit of Detection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/dta.2250","doi":"https://doi.org/10.1002/dta.2250","is_oa":false,"landing_page_url":"https://doi.org/10.1002/dta.2250","pdf_url":null,"source":{"id":"https://openalex.org/S36361591","display_name":"Drug Testing and Analysis","issn_l":"1942-7603","issn":["1942-7603","1942-7611"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Testing and Analysis","raw_type":"journal-article"},{"id":"pmid:28743169","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28743169","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug testing and analysis","raw_type":"Journal Article"},{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/590703","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28743169","pdf_url":null,"source":{"id":"https://openalex.org/S7407055369","display_name":"Lirias","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Drug Testing and Analysis, vol. 10 (3), Art.No. 10.1002/dta.2250, (592-596)","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3792185679","display_name":null,"funder_award_id":"IOF/KP/12/002 and C22/15/025","funder_id":"https://openalex.org/F4320322308","funder_display_name":"KU Leuven"},{"id":"https://openalex.org/G5236196061","display_name":null,"funder_award_id":"G061712","funder_id":"https://openalex.org/F4320321730","funder_display_name":"Fonds Wetenschappelijk Onderzoek"}],"funders":[{"id":"https://openalex.org/F4320321730","display_name":"Fonds Wetenschappelijk Onderzoek","ror":"https://ror.org/03qtxy027"},{"id":"https://openalex.org/F4320322308","display_name":"KU Leuven","ror":"https://ror.org/05f950310"},{"id":"https://openalex.org/F4320335514","display_name":"Universitaire Ziekenhuizen Leuven, KU Leuven","ror":"https://ror.org/0424bsv16"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1991810959","https://openalex.org/W2041167828","https://openalex.org/W2072724102","https://openalex.org/W2075707946","https://openalex.org/W2075732524","https://openalex.org/W2092863985","https://openalex.org/W2101168807","https://openalex.org/W2105772684","https://openalex.org/W2115112939","https://openalex.org/W2129457078","https://openalex.org/W2194538548","https://openalex.org/W2291975188","https://openalex.org/W2300110679","https://openalex.org/W2307567353","https://openalex.org/W2336728470","https://openalex.org/W2591310089"],"related_works":["https://openalex.org/W4214898668","https://openalex.org/W2194538548","https://openalex.org/W4393005519","https://openalex.org/W7168259860","https://openalex.org/W2789530224","https://openalex.org/W4403978429","https://openalex.org/W2586738790","https://openalex.org/W2591310089","https://openalex.org/W2914698404","https://openalex.org/W2620299091"],"abstract_inverted_index":{"Therapeutic":[0],"drug":[1],"monitoring":[2],"of":[3,27,105,129,153,170,176,185],"adalimumab":[4,36,55,96,108,202,212],"is":[5],"recommended":[6],"to":[7,31,43,84,93,194],"improve":[8],"therapeutic":[9],"outcome":[10],"in":[11,99,214],"patients":[12,106,215],"with":[13,107,124,165,216],"Crohn's":[14,217],"disease.":[15,218],"Performing":[16],"an":[17,76,162,173],"ELISA":[18,160],"requires":[19,142],"a":[20,47,53,59,121,127,137,149,166,187,206],"rather":[21],"long":[22],"time-to-result":[23],"and":[24,45,78,112,158,172,182,199],"the":[25,33,118,140,156,159,183,195],"necessity":[26],"collecting":[28],"multiple":[29],"samples":[30,104],"decrease":[32],"cost":[34],"per":[35],"determination.":[37],"In":[38],"this":[39],"study,":[40],"we":[41,68],"aim":[42],"develop":[44],"validate":[46],"rapid":[48],"assay":[49,180],"suitable":[50],"for":[51,147,211],"measuring":[52,148,186],"single":[54,150,188],"serum":[56],"sample":[57,122,189],"using":[58],"fiber-optic":[60],"surface":[61],"plasmon":[62],"resonance":[63],"(FO-SPR)":[64],"based":[65],"sensor.":[66],"Therefore,":[67],"have":[69],"immobilized":[70],"MA-ADM28B8":[71],"as":[72,81],"capture":[73],"antibody":[74,83],"on":[75],"FO-probe":[77],"conjugated":[79],"MA-ADM40D8":[80],"detecting":[82],"gold":[85],"nanoparticles.":[86],"A":[87],"dose-response":[88],"curve":[89],"ranging":[90],"from":[91],"2.5":[92],"40":[94],"ng/mL":[95],"was":[97],"obtained":[98],"1/400":[100],"diluted":[101],"serum.":[102],"Serum":[103],"concentrations":[109],"between":[110,155],"1":[111],"16":[113,130],"\u03bcg/mL":[114],"were":[115],"measured":[116],"whereas":[117],"negative":[119],"control,":[120],"spiked":[123],"infliximab":[125],"at":[126],"concentration":[128],"\u03bcg/mL,":[131],"showed":[132],"no":[133],"significant":[134],"signal.":[135],"Using":[136],"pre-functionalized":[138],"FO-probe,":[139],"technology":[141],"less":[143],"than":[144],"45":[145],"minutes":[146],"sample.":[151],"Comparison":[152],"measurements":[154],"biosensor":[157,203],"revealed":[161],"excellent":[163],"agreement":[164],"Pearson":[167],"r":[168],"coefficient":[169,175],"0.99":[171],"intra-class":[174],"0.99.":[177],"The":[178,197],"reduced":[179],"time":[181],"possibility":[184],"are":[190],"major":[191],"advantages":[192],"compared":[193],"ELISA.":[196],"developed":[198],"validated":[200],"optical":[201],"could":[204],"be":[205],"valuable":[207],"point-of-care":[208],"diagnostic":[209],"tool":[210],"quantification":[213]},"counts_by_year":[{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2017-07-31T00:00:00"}